37.24
25-August-25 11:17:00
15 minutes delayed
Stocks
-1.88
-4.81%
Today's range
37.21 - 39.37
ISIN
N/A
Source
NASDAQ
Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021
25 Feb 2021 06:00:01 By Nasdaq GlobeNewswire
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
09 Feb 2021 04:00:00 By Nasdaq GlobeNewswire